50jili guess the game
Red Bulls go into MLS Cup final with distinctly Canadian flavour in front officeMan Utd cult hero Nani announces retirement with emotional video after tragic death of his father
Amgen Logo. (PRNewsFoto/Amgen) (PRNewsFoto/) THOUSAND OAKS, Calif. , Dec. 10, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.38 per share dividend for the first quarter of 2025. The dividend will be paid on March 7, 2025 , to all stockholders of record as of the close of business on February 14, 2025 . About Amgen Amgen discovers, develops, manufactures and delivers innovative medicines to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. In 2024, Amgen was named one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best Large Employers" by Forbes, among other external recognitions . Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average ® , and it is also part of the Nasdaq-100 Index ® , which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization. For more information, visit Amgen.com and follow Amgen on X , LinkedIn , Instagram , TikTok , YouTube and Threads . Forward-Looking Statements This news release contains forward-looking statements that are based on the current expectations and beliefs of Amgen. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including any statements on the outcome, benefits and synergies of collaborations, or potential collaborations, with any other company (including BeiGene, Ltd. or Kyowa Kirin Co., Ltd.), the performance of Otezla® (apremilast) (including anticipated Otezla sales growth and the timing of non-GAAP EPS accretion), our acquisitions of Teneobio, Inc., ChemoCentryx, Inc., or Horizon Therapeutics plc (including the prospective performance and outlook of Horizon's business, performance and opportunities, any potential strategic benefits, synergies or opportunities expected as a result of such acquisition, and any projected impacts from the Horizon acquisition on our acquisition-related expenses going forward), as well as estimates of revenues, operating margins, capital expenditures, cash, other financial metrics, expected legal, arbitration, political, regulatory or clinical results or practices, customer and prescriber patterns or practices, reimbursement activities and outcomes, effects of pandemics or other widespread health problems on our business, outcomes, progress, and other such estimates and results. Forward-looking statements involve significant risks and uncertainties, including those discussed below and more fully described in the Securities and Exchange Commission reports filed by Amgen, including our most recent annual report on Form 10-K and any subsequent periodic reports on Form 10-Q and current reports on Form 8-K. Unless otherwise noted, Amgen is providing this information as of the date of this news release and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise. No forward-looking statement can be guaranteed and actual results may differ materially from those we project. Our results may be affected by our ability to successfully market both new and existing products domestically and internationally, clinical and regulatory developments involving current and future products, sales growth of recently launched products, competition from other products including biosimilars, difficulties or delays in manufacturing our products and global economic conditions. In addition, sales of our products are affected by pricing pressure, political and public scrutiny and reimbursement policies imposed by third-party payers, including governments, private insurance plans and managed care providers and may be affected by regulatory, clinical and guideline developments and domestic and international trends toward managed care and healthcare cost containment. Furthermore, our research, testing, pricing, marketing and other operations are subject to extensive regulation by domestic and foreign government regulatory authorities. We or others could identify safety, side effects or manufacturing problems with our products, including our devices, after they are on the market. Our business may be impacted by government investigations, litigation and product liability claims. In addition, our business may be impacted by the adoption of new tax legislation or exposure to additional tax liabilities. If we fail to meet the compliance obligations in the corporate integrity agreement between us and the U.S. government, we could become subject to significant sanctions. Further, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent applications may be challenged, invalidated or circumvented by our competitors, or we may fail to prevail in present and future intellectual property litigation. We perform a substantial amount of our commercial manufacturing activities at a few key facilities, including in Puerto Rico , and also depend on third parties for a portion of our manufacturing activities, and limits on supply may constrain sales of certain of our current products and product candidate development. An outbreak of disease or similar public health threat, such as COVID-19, and the public and governmental effort to mitigate against the spread of such disease, could have a significant adverse effect on the supply of materials for our manufacturing activities, the distribution of our products, the commercialization of our product candidates, and our clinical trial operations, and any such events may have a material adverse effect on our product development, product sales, business and results of operations. We rely on collaborations with third parties for the development of some of our product candidates and for the commercialization and sales of some of our commercial products. In addition, we compete with other companies with respect to many of our marketed products as well as for the discovery and development of new products. Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new indication for an existing product will be successful and become a commercial product. Further, some raw materials, medical devices and component parts for our products are supplied by sole third-party suppliers. Certain of our distributors, customers and payers have substantial purchasing leverage in their dealings with us. The discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations. Our efforts to collaborate with or acquire other companies, products or technology, and to integrate the operations of companies or to support the products or technology we have acquired, may not be successful. There can be no guarantee that we will be able to realize any of the strategic benefits, synergies or opportunities arising from the Horizon acquisition, and such benefits, synergies or opportunities may take longer to realize than expected. We may not be able to successfully integrate Horizon, and such integration may take longer, be more difficult or cost more than expected. A breakdown, cyberattack or information security breach of our information technology systems could compromise the confidentiality, integrity and availability of our systems and our data. Our stock price is volatile and may be affected by a number of events. Our business and operations may be negatively affected by the failure, or perceived failure, of achieving our environmental, social and governance objectives. The effects of global climate change and related natural disasters could negatively affect our business and operations. Global economic conditions may magnify certain risks that affect our business. Our business performance could affect or limit the ability of our Board of Directors to declare a dividend or our ability to pay a dividend or repurchase our common stock. We may not be able to access the capital and credit markets on terms that are favorable to us, or at all. CONTACT: Amgen, Thousand Oaks Elissa Snook , 609-251-1407 (media) Justin Claeys , 805-313-9775 (investors) View original content to download multimedia: https://www.prnewswire.com/news-releases/amgen-announces-2025-first-quarter-dividend-302328180.html SOURCE Amgen
ICEYE expands its Earth Observation capabilities with launch of two SAR satellites for mid-inclination orbit on the Bandwagon-2 mission with SpaceXNEW YORK -- As New York City prosecutors work to bring murder charges against Luigi Mangione in the brazen killing of UnitedHealthcare CEO Brian Thompson, supporters of the suspect are donating tens of thousands of dollars for a defense fund established for him, leaving law enforcement officials worried Mangione is being turned into a martyr. Several online defense funds have been created for Mangione by anonymous people, including one on the crowdfunding website GiveSendGo that as of Sunday morning had raised over $100,000. NOTE: The video above is from a previous report. The GiveSendGo defense fund for the 26-year-old Mangione was established by an anonymous group calling itself "The December 4th Legal Committee," apparently in reference to the day Mangione allegedly ambushed and gunned down Thompson in Midtown Manhattan as the executive walked to his company's shareholders conference at the New York Hilton hotel. "We are not here to celebrate violence, but we do believe in the constitutional right to fair legal representation," the anonymous group said in a statement. The crowdfunding campaign prompted donations from thousands of anonymous donors across the country, many of them leaving messages of support for Mangione, including one person who called themselves "A frustrated citizen" and thanked Mangione for "sparking the awareness and thought across this sleeping nation." The GiveSendGo fund for Mangione appeared to be briefly taken down before it was restored on Thursday. In a statement to ABC News, a spokesperson for GiveSendGo said the company "operates with a principle of not preemptively determining guilt or innocence." "Our platform does not adjudicate legal matters or the validity of causes. Instead, we allow campaigns to remain live unless they violate the specific terms outlined in our Terms of Use. Importantly, we do allow campaigns for legal defense funds, as we believe everyone deserves the opportunity to access due process," the GiveSendGo spokesperson said. The spokesperson added, "We understand the concerns raised by such campaigns and take these matters seriously. When campaigns are reported, our team conducts a thorough review to ensure they comply with our policies. While other platforms may choose a different approach, GiveSendGo's core value is to provide a space where all individuals, no matter their situation, can seek and receive support, with donors making their own informed decisions." Other crowdfunding sites such as GoFundMe have also taken down campaigns soliciting donations for Mangione's defense. "GoFundMe's Terms of Service prohibit fundraisers for the legal defense of violent crimes," the crowdfunding website said in a statement. "The fundraisers have been removed from our platform and all donors have been refunded."Amazon and Etsy have removed from their websites merchandise featuring Mangione, including T-shirts and tote bags reading "Free Luigi" and the phrase "Deny, Defend, Depose," words police said were etched in the shell casings discovered at the scene of Thompson's homicide. "Celebrating this conduct is abhorrent to me. It's deeply disturbing," Manhattan District Attorney Alvin Bragg told ABC News senior investigative reporter Aaron Katersky in an interview Wednesday night. "And what I would say to members of the public, people who as you described are celebrating this and maybe contemplating other action, that we will be vigilant and we will hold people accountable. We are at the ready." Prosecutors at the Manhattan district attorney's office have begun presenting evidence to a grand jury as they work to try to secure an indictment against Mangione, sources told ABC News on Thursday. Mangione's attorney, Thomas Dickey of Altoona, Pennsylvania, where the suspect was arrested Monday following a five-day manhunt, said his client is presumed innocent and will plead not guilty to any charges filed against him. Mangione is contesting extradition to New York. Asked about people contributing to Mangione defense funds that have popped up, Dickey said, "People are entitled to their opinion and, like I said, if you're an American and you believe in the American criminal justice system, you have to presume him to be innocent and none of us would want anything other than that if that were us in their shoes. So, I'm glad he had some support." In a later interview on CNN, Dickey said he is leaning toward not accepting any money from his client's supporters for his defense. "To be honest with you, I probably wouldn't," Dickey told CNN. "I just don't feel comfortable about that. So, I don't know. I haven't given that much thought. Obviously, my client appreciates the support that he has, but I don't know, it just doesn't sit right with me, really." Retired FBI special agent Richard Frankel said that in previous politically-charged violent crimes, suspects have received unsolicited support. "We saw it with the Unabomber," said Frankel, an ABC News contributor, referring to Ted Kaczynski -- the mathematician-turn-domestic terrorist who blamed technology for a decline of individual freedom and mailed handcrafted explosives to targeted individuals between 1978 and 1995. Frankel said Eric Rudolph, who detonated a bomb in Atlanta's Centennial Olympic Park during the 1996 Olympic Games and carried out three additional bombings as he eluded capture for five years, also attracted supporters. "In my opinion, they're supporting individuals who have committed potentially terrorist acts, but it's a politically charged act," Frankel said Referring to the Thompson killing, Frankel added, "You can be up in arms about the healthcare industry, but you can't threaten or actually hurt members of the healthcare industry." Most recently, Marine veteran Daniel Penny was acquitted of criminally negligent homicide in the chokehold death of Jordan Neely, a homeless man who was acting erratically on a New York City subway, after supporters donated more than $3 million to his legal defense fund. Law enforcement officials have expressed concern that Mangione is being turned into a martyr. Someone this week pasted "wanted posters" outside the New York Stock Exchange naming other executives. A bulletin released Wednesday by the Delaware Valley Intelligence Center, a multi-agency law enforcement intelligence-sharing network based in Philadelphia, included a photo of a banner hanging from an overpass reading, "Deny, Defend, Depose." "Many social media users have outright advocated for the continued killings of CEOs with some aiming to spread fear by posting 'hit lists,'" the bulletin, obtained by ABC News, reads. Meanwhile, New York Police Department investigators continue to build a murder case against Mangione, who is being held in Pennsylvania on charges stemming from his arrest there, including illegal possession of ghost gun and fraudulent identification. Mangione has pleaded not guilty to the charges in Pennsylvania. On Wednesday, NYPD Commissioner Jessica Tisch said that the three shell casings recovered at the scene of Thompson's shooting matched the gun found in Mangione possession when he was arrested. She also confirmed that Mangione's fingerprints were recovered from a water bottle and the wrapper of a granola bar found near the crime scene.
Naporafenibum is a small molecule commercialized by Erasca, with a leading Phase III program in Metastatic Melanoma. According to Globaldata, it is involved in 11 clinical trials, of which 1 was completed, 7 are ongoing, 1 is planned, and 2 were terminated. Smarter leaders trust GlobalData The gold standard of business intelligence. The revenue for Naporafenibum is expected to reach an annual total of $90 mn by 2036 in the US based off GlobalData’s Expiry Model. The drug’s revenue forecasts along with estimated costs are used to measure the value of an investment opportunity in that drug, otherwise known as net present value (NPV). Applying the drug’s phase transition success rate to remaining R&D costs and likelihood of approval (LoA) to sales related costs provides a risk-adjusted NPV model (rNPV). The rNPV model is a more conservative valuation measure that accounts for the risk of a drug in clinical development failing to progress. Naporafenibum Overview Naporafenib (LXH-254) is under development for the treatment of advanced unresectable or metastatic solid tumor, metastatic melanoma, metastatic colorectal cancer, colon cancer, non small cell lung cancer. The drug candidate is administered orally. It acts by targeting pan RAF kinase. It is a new molecular entity (NME). Erasca Overview Erasca is an oncology drug development company that uses its artificial intelligence drug discovery platform to treat and cure cancer. The company is headquartered in San Diego, California, the US. The operating loss of the company was US$247.5 million in FY2022, compared to an operating loss of US$107.4 million in FY2021. The net loss of the company was US$242.8 million in FY2022, compared to a net loss of US$122.8 million in FY2021. For a complete picture of Naporafenibum’s valuation, This content was updated on 11 March 2024 From Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors. , the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. To create this model, GlobalData takes into account factors including patent law, known and projected regulatory approval processes, cash flows, drug margins and company expenses. Combining these data points with GlobalData’s world class analysis creates high value models that companies can use to help in evaluation processes for each drug or company. The rNPV method integrates the probability of a drug reaching a clinical stage into the cash flow at that time, which provides a more accurate valuation, as it considers the probability that the drug never makes it through the clinical pathway to commercialization. GlobalData’s rNPV model uses proprietary likelihood of approval (LoA) and phase transition success rate (PTSR) data for the indication in the highest development stage, which can be found on GlobalData’s .Column: How veterans can lead America’s fight for unityEverything You Need to Know About Shingles & the Shingles Vaccine
FG Constructs Modern, Smart Police Divisional Headquarters in AbujaMedical Power Supply Market Future Business Opportunities 2024-2031 12-21-2024 05:20 PM CET | Health & Medicine Press release from: Coherent Market Insights Medical Power Supply Market Trends Overview 2024-2031: A new Report by Coherent Market Insights, titled "Medical Power Supply Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031," offers a comprehensive analysis of the industry, which comprises insights on the Medical Power Supply market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market. This report has a complete table of contents, figures, tables, and charts, as well as insightful analysis. The Medical Power Supply market has been growing significantly in recent years, driven by a number of key factors, such as increasing demand for its products, expanding customer base, and technological advancements. This report provides a comprehensive analysis of the Medical Power Supply market, including market size, trends, drivers and constraints, Competitive Aspects, and prospects for future growth. Purchase Now Up to 45% Discount on This Premium Report @ https://www.coherentmarketinsights.com/promo/buynow/101832 The purpose of the market research study is to thoroughly investigate the industry in order to gain knowledge of the industry and its economic potential. As a result, the client has a complete knowledge of the market and business from past, present, and prospective aspects enabling them to allocate resources and investing money wisely. Scope of the Medical Power Supply Market: The Medical Power Supply market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2021, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon. Geographical Landscape of the Medical Power Supply market: The Medical Power Supply Market report provides information about the market area, which is further subdivided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. » North America (United States, Canada, and Mexico) » Europe (Germany, France, UK, Russia, Italy) » Asia-Pacific (China, Japan, Korea, India, and Southeast Asia) » Latin America (Brazil, Argentina, Colombia) » Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa) This report offers actionable growth insights and an extensive study comprising secondary research, primary interviews with industry stakeholders, and competitors, validation, and triangulation with the Coherent Market Insights regional database. Experts have detailed primary records with the market players across the value chain in all regions and industry experts to obtain qualitative and quantitative insights. Trends and Opportunities of the Medical Power Supply Market: The Medical Power Supply market has seen several trends in recent years, and understanding these trends is crucial to stay ahead of the competition. This report also presents several opportunities for players in the market. The increasing demand for Medical Power Supply in various industries presents several growth opportunities for players in the market. Key Benefits for Stakeholders: ⏩ The study includes a comprehensive analysis of current Medical Power Supply Market trends, estimations, and market size dynamics from 2024 to 2031 in order to identify the most potential prospects. ⏩ The five forces study by Porter underlines the role of buyers and suppliers in aiding stakeholders in making profitable business decisions and expanding their supplier-buyer network. ⏩ In-depth research, as well as market size and segmentation, can assist you in identifying current Medical Power Supply Market opportunities. ⏩ The largest countries in each area are mapped based on their market revenue contribution. ⏩ The Medical Power Supply Market research report provides an in-depth analysis of the top competitors in the Medical Power Supply Market. Purchase Now Up to 45% Discount on This Premium Report @ https://www.coherentmarketinsights.com/promo/buynow/101832 Reasons to buy: 👉 Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies. 👉 Recognize emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. 👉 Classify potential new clients or partners in the target demographic. 👉 Develop tactical initiatives by understanding the focus areas of leading companies. 👉 Plan mergers and acquisitions meritoriously by identifying Top Manufacturers. 👉 Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope. 👉 Suitable for supporting your internal and external presentations with reliable high-quality data and analysis. FAQ's Q.1 What are the main factors influencing the Medical Power Supply market? Q.2 Which companies are the major sources in this industry? Q.3 What are the market's opportunities, risks, and general structure? Q.4 Which of the top Medical Power Supply Market companies compare in terms of sales, revenue, and prices? Q.5 Which businesses serve as the Medical Power Supply market's distributors, traders, and dealers? Q.6 How are market types and applications and deals, revenue, and value explored? Q.7 What does a business area's assessment of agreements, income, and value implicate? Author of this marketing PR: Alice Mutum is a seasoned senior content editor at Coherent Market Insights, leveraging extensive expertise gained from her previous role as a content writer. With seven years in content development, Alice masterfully employs SEO best practices and cutting-edge digital marketing strategies to craft high-ranking, impactful content. As an editor, she meticulously ensures flawless grammar and punctuation, precise data accuracy, and perfect alignment with audience needs in every research report. Alice's dedication to excellence and her strategic approach to content make her an invaluable asset in the world of market insights. 📌Contact Us: Mr. Shah Coherent Market Insights Pvt. Ltd, 📞U.S.: +1-206-701-6702 📞U.K.: +44-020-8133-4027 📞AUS: +61-2-4786-0457 📞INDIA: +91-848-285-0837 ✉ Email: sales@coherentmarketinsights.com About Us: Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients. This release was published on openPR.
W hen Jorge Rivera-Herrans released part of Epic: the Musical last Christmas, he managed to push Taylor Swift off the top of the US iTunes album charts. So there is a lot at stake when the final instalment of his musical retelling of the Odyssey is released on Christmas Day. Rivera-Herrans’s project has already been an extraordinary success, with more monthly listeners on Spotify (1.6m) than veterans such as Morrissey, Liam Gallagher, or the Sex Pistols, and 119m plays on the platform in the past 28 days alone. “I wanted to have sword fights and the ocean, and I wanted to have gods and monsters, and spells and love and lust and revenge,” he told the Observer . “I want people to have this feeling of wonder, that people can watch it and feel like a child again.” Epic is a musical, but not a theatre production. At least, not yet. It is a 40-track concept album with Rivera-Herrans singing the part of Odysseus on his 10-year voyage home to Ithaca after the siege of Troy, with each step released on TikTok . Epic feeds two obsessions of teenagers at the vanguard of generation Alpha: Greek mythology and fan participation. Rivera-Herrans began writing and recording in his bedroom studio, later building a soundproofed vocal booth with his father. While most artists are determined not to risk spoiling their magic by revealing creative secrets, Rivera-Herrans is the opposite. He has shared everything from song motifs to orchestration choices and the audition process. “I was terrified at first,” he said. “The first time I put a video on TikTok I was so nervous I did not sleep that night. But it’s one of the best things I’ve ever done, because what’s so cool about getting to show the process online is that we’re all on an odyssey together. You get to see in real time what works and what doesn’t.” The first songs were solo affairs, but Rivera-Herrans then held auditions on TikTok, with candidates posting their own videos singing along to his music. “I thought we were going to get maybe 30 auditions, but we had 1,000 video submissions by the end of the month,” he said. Fans have also created their own animations to bring Epic’ s songs to life and Rivera-Herrans relishes their interactions. “If I tried dropping a hint of something happening in an earlier song – I do a lot of clues through musical motifs – will people pick up on it? When they do, it’s so rewarding.” Perhaps the most obscure leitmotif spotted by fans is a trumpet melody that signals Poseidon is responsible for the storm that keeps Odysseus and his crew at sea for years, without the god appearing in the scene. It’s only later on that the theme returns, sung by the god. “It’s so awesome that people were able to [work it out],” Rivera-Herrans said. “We’re figuring out cool ways of doing storytelling as we do this, and it’s so exciting.” Fan participation in musical theatre has been growing since composers began sharing work on YouTube in about 2015, according to Clare Chandler, a senior lecturer in musical theatre at University of Lincoln’s school of creative arts. Sign up to Observed Analysis and opinion on the week's news and culture brought to you by the best Observer writers after newsletter promotion Be More Chill , a show about an awkward high school student trying to become cool, originally produced at a theatre in New Jersey, became a minor hit when the cast album was picked up by Spotify’s algorithm. After gaining momentum online, it sold out off-Broadway, where people came “from across the world to see” it, Chandler said, and then it moved to Broadway. “[It] goes from something that was disregarded, through this virtual Broadway environment to be something that becomes staged on Broadway because of its popularity.” The pandemic fuelled the rise of two other TikTok musicals. First came Ratatouille , which emerged from the online meme culture that had grown around the Pixar movie. A variety of TikTok users composed songs and the Ratatousical ended up on Broadway for a one-off charity show. Then Abigail Barlow and Emily Bear created the Unofficial Bridgerton Musical after Barlow posted a video of her singing a fragment of a verse. They won a Grammy for best musical theatre album, but attempts to actually stage the show prompted a lawsuit from Netflix. The question Epic fans have been asking all along is whether they will get to see it on stage. After the final saga drops on Christmas Day, when Odysseus finally arrives in Ithaca, they may get the answer. Rivera-Herrans and his team are in talks with what they describe as a “very high- level company” to make an animated movie, and with another to create a live action stage show. Three video games are planned, with two already on the way. And the team is conscious that fans will want to be involved in the process of bringing these things to life. “What is the next version of Epic that we put out into the world? I’m so open for all of the options, because in each different version we can convey different aspects of the story,” Rivera-Herrans said.The Bruins activated depth defenseman Alec Regula from season-opening injured reserve on Tuesday and subsequently placed him on waivers for the purpose of assignment to AHL Providence, Elliotte Friedman of Sportsnet reports. Regula, 24, has yet to play this season after suffering a knee injury over the offseason. It held him out of the entirety of Boston’s training camp and preseason schedule and earned him a non-roster designation when the regular season began. It was an inauspicious start to the 2024-25 campaign for Regula, who spent all of last season in the minors after seeing NHL ice in his previous three professional seasons. Acquired from the Blackhawks in the 2023 Taylor Hall/Nick Foligno trade, Regula led the AHL last season with a +36 rating and added four goals and 26 points in 55 games for Providence, tying his previous career highs. When Regula can expect to touch NHL ice next is anybody’s guess. The 6-foot-4, 211-pound righty made 22 NHL appearances while with Chicago, scoring one goal and logging a -5 rating while averaging 16:54 per game. Initially a 2018 third-round pick of the Red Wings, he’s firmly established himself as a top two-way threat at the AHL level, but has yet to demonstrate marginally positive possession impacts in his NHL minutes. There are likely a few names ahead of Regula who are in line for a recall, namely Ian Mitchell, who leads Providence defenders in scoring with 13 points in 22 games. Whether or not he ends up seeing NHL action during the one-year, two-way deal he inked last summer remains to be seen, but a strong showing in his delayed start to the season should help him at least earn a qualifying offer at season’s end. This article first appeared on Pro Hockey Rumors and was syndicated with permission.
Confronting 'neijuan': China addresses unhealthy competitionCollege Football Playoff's first 12-team bracket is set with Oregon No. 1 and SMU in, Alabama out SMU captured the last open spot in the 12-team College Football Playoff, bumping Alabama to land in a bracket that placed undefeated Oregon at No. 1. The selection committee preferred the Mustangs, losers of a heartbreaker in the Atlantic Coast Conference title game, who had a far less difficult schedule than Alabama of the SEC but one fewer loss. The inaugural 12-team bracket marks a new era for college football, though the Alabama-SMU debate made clear there is no perfect formula. The tournament starts Dec. 20-21 with four first-round games. It concludes Jan. 20 with the national title game in Atlanta. Alabama left out of playoff as committee rewards SMU's wins over Crimson Tide's strong schedule The College Football Playoff committee took wins over strength of schedule, taking SMU over Alabama for the final at-large spot in the field. The field was expanded from four to 12 teams this season, but that didn’t save the committee from controversy. SMU showed it could compete against a traditional power, losing to Clemson 34-31 on a 56-yard field goal in the ACC title game on Saturday. Alabama had some ups and downs in its first season under coach Kalen DeBoer. The Crimson Tide had quality wins against Georgia and South Carolina, but lost at Vanderbilt, Tennessee and Oklahoma. Big Ten wins playoff selection derby, followed by SEC despite notable Alabama omission College football’s conference shakeup left concerns about two super conferences dominating the playoff field. They weren’t totally unfounded, or 100% born out. The Big Ten, not the Southeastern Conference, was the biggest winner. The ACC scored, too. The Big Ten led the initial 12-team playoff field with four making the cut, topped by a No. 1 Oregon team that was part of the Pac-12 exodus. Then came the SEC — and one notable omission. ACC runner-up SMU got the nod over college football blue-blood Alabama, another blemish in Kalen DeBoer’s first season as Nick Saban’s championship-or-bust successor. Tamar Bates scores 29 points to help Missouri beat No. 1 Kansas 76-67 COLUMBIA, Mo. (AP) — Tamar Bates had 29 points and five steals to help Missouri beat Hunter Dickinson and No. 1 Kansas 76-67. Mark Mitchell scored 17 points in Missouri’s first win over Kansas since a 74-71 victory on Feb. 4, 2012. Anthony Robinson II had 11 points and five steals for the 8-1 Tigers. Dickinson had 19 points and 14 rebounds, but he also committed seven turnovers. The 7-2 Jayhawks have lost two straight on the road after falling 76-63 against Creighton on Wednesday night. Scottie Scheffler ends his big year in the Bahamas with his 9th victory NASSAU, Bahamas (AP) — Scottie Scheffler ended his biggest year with another victory. Scheffler was coming off a two-month break and looked as good as ever. He shot 63 in the Hero World Challenge and set tournament records at Albany with a 72-hole total of 263 and a six-shot victory. Tom Kim was the runner-up and Justin Thomas finished third. Scheffler ends his year with nine victories in 21 tournaments. That includes the holiday tournament in the Bahamas and the Olympic gold medal in Paris. It's the third-highest winning percentage in the last 40 years. Tournament host Tiger Woods had two better years. Lindsey Vonn is encouraged by how close she is to being competitive in ski racing return at age 40 COPPER MOUNTAIN, Colo. (AP) — Lindsey Vonn is encouraged by how close she is to being competitive again in her ski racing return at 40 years old. Vonn is still getting her ski equipment dialed in and getting used to going full speed again on her new titanium knee. That’s why all that she's reading into being more than two seconds behind in a pair of lower-level super-G races Sunday is that she’s right there. This after nearly six years away from ski racing and an abbreviated prep period. She was 2.19 seconds behind in the first race and 2.06 in the second. Both were won by her American teammate Lauren Macuga. Plane circles MetLife Stadium with message to co-owner John Mara to fix the Giants' 'dumpster fire' EAST RUTHERFORD, N.J. (AP) — A small plane circled MetLife Stadium roughly 90 minutes before New York was to play host to the New Orleans Saints on Sunday, asking Giants co-owner John Mara to overhaul the team that has made the playoffs twice since winning the Super Bowl in February 2012. “Mr. Mara, enough. Please fix this dumpster fire!” the message read as it was towed behind the rear of a small plane. Saquon Barkley sets Eagles season rushing record and has Dickerson's NFL mark in his sights PHILADELPHIA (AP) — Saquon Barkley has broken LeSean McCoy's Eagles franchise record for rushing yards in a season. Barkley has 1,623 yards. He surpassed McCoy's mark of 1,607 yards with a 9-yard run in Sunday's 22-16 win over Carolina. Barkley finished the game with 124 yards, within a yard of his season average. He has four games left and is on pace to break Eric Dickerson's 40-year-old NFL record of 2,105 yards. Dickerson set that record in a 16-game season and Barkley has one more game. Eagles fans serenaded Barkley with “MVP!” chants and McCoy congratulated him on social media. Tua Tagovailoa's TD pass to Jonnu Smith gives Dolphins 32-26 overtime win over Aaron Rodgers, Jets MIAMI GARDENS, Fla. (AP) — Tua Tagovailoa threw a 10-yard touchdown pass to Jonnu Smith in overtime and the Miami Dolphins overcame Aaron Rodgers’ first 300-yard passing game in nearly three years to beat the New York Jets 32-26. After Jason Sanders tied it with 7 seconds left in regulation with a 42-yard field goal, Tagovailoa quickly moved the Dolphins down the field and they beat the Jets for the ninth straight time in Miami. That came after Anders Carlson gave the struggling Jets the lead with a 42-yarder with 52 seconds remaining. New York was eliminated from playoff contention for the 14th straight year. Steelers WR George Pickens to miss first game of his career with hamstring injury PITTSBURGH (AP) — Pittsburgh Steelers wide receiver George Pickens will have to wait to “introduce” himself to Cleveland Browns defensive back Greg Newsome II. Pickens is inactive for Pittsburgh's rematch against the Browns because of a hamstring injury. Newsome and Pickens ended Cleveland’s 24-19 win on Nov. 21 by tussling on Pittsburgh’s last-gasp desperation pass attempt. Pickens grabbed Newsome’s facemask as the two careened through the end zone and slammed into a restraining wall. Afterward, Newsome called the mercurial Pickens a “fake tough guy.” Pickens responded on Friday by feigning ignorance and saying he didn’t even know who Newsome was when asked if he would talk to Newsome before the game.
"I am the happiest person today, more than you or your family, as our painstaking efforts to convince you to surrender and join the mainstream has bore fruit," Union Home Minister Amit Shah told a group of former Naxals on Sunday. The event here, attended by about 30 surrendered Naxals and insurgents belonging to six states -- Chhattisgarh, Odisha, Maharashtra, Telangana, Andhra Pradesh and Assam -- may be small but is very significant, Shah said. "I am getting immense satisfaction that the country's youngsters are responding to our appeal, realising the futility of violence and surrendering," he said. Shah said when Prime Minister Narendra Modi gave him responsibility of the home ministry in 2019, he thought that those who were involved in armed movements should be given a chance to lay down their arms, surrender and live a peaceful life. "Following our initiatives, 20 peace accords were signed in the northeast and 9,000 militants surrendered," he said. The Centre has formulated rehabilitation policies for surrendered militants and Naxals, including those injured in violence, the home minister said. Finance Financial Literacy for Non-Finance Executives By - CA Raja, Chartered Accountant | Financial Management Educator | Former AVP - Credit, SBI View Program Marketing Modern Marketing Masterclass by Seth Godin By - Seth Godin, Former dot com Business Executive and Best Selling Author View Program Web Development Master RESTful APIs with Python and Django REST Framework: Web API Development By - Metla Sudha Sekhar, IT Specialist and Developer View Program Artificial Intelligence(AI) Learn InVideo AI: Create Videos from Text Easily By - Prince Patni, Software Developer (BI, Data Science) View Program Marketing Future of Marketing & Branding Masterclass By - Dr. David Aaker, Professor Emeritus at the Haas School of Business, UC Berkeley, Author | Speaker | Thought Leader | Branding Consultant View Program Artificial Intelligence(AI) Master in Python Language Quickly Using the ChatGPT Open AI By - Metla Sudha Sekhar, IT Specialist and Developer View Program Entrepreneurship Validating Your Startup Idea: Steps to Ensure Market Fit By - Dr. Anu Khanchandani, Startup Coach with more than 25 years of experience View Program Legal Complete Guide to AI Governance and Compliance By - Prince Patni, Software Developer (BI, Data Science) View Program Office Productivity Mastering Microsoft Office: Word, Excel, PowerPoint, and 365 By - Metla Sudha Sekhar, IT Specialist and Developer View Program Entrepreneurship Boosting Startup Revenue with 6 AI-Powered Sales Automation Techniques By - Dr. Anu Khanchandani, Startup Coach with more than 25 years of experience View Program Design Microsoft Designer Guide: The Ultimate AI Design Tool By - Prince Patni, Software Developer (BI, Data Science) View Program Astrology Vastu Shastra Course By - Sachenkumar Rai, Vastu Shashtri View Program Artificial Intelligence(AI) Java Programming with ChatGPT: Learn using Generative AI By - Metla Sudha Sekhar, IT Specialist and Developer View Program Artificial Intelligence(AI) AI and Analytics based Business Strategy By - Tanusree De, Managing Director- Accenture Technology Lead, Trustworthy AI Center of Excellence: ATCI View Program Data Analysis Animated Visualizations with Flourish Studio: Beginner to Pro By - Prince Patni, Software Developer (BI, Data Science) View Program Artificial Intelligence(AI) Basics of Generative AI: Unveiling Tomorrow's Innovations By - Metla Sudha Sekhar, IT Specialist and Developer View Program Web Development A Comprehensive ASP.NET Core MVC 6 Project Guide for 2024 By - Metla Sudha Sekhar, IT Specialist and Developer View Program Web Development Intermediate C++ Skills: Master Pointers, Structures and File Stream By - Metla Sudha Sekhar, IT Specialist and Developer View Program Finance AI and Generative AI for Finance By - Hariom Tatsat, Vice President- Quantitative Analytics at Barclays View Program Finance Crypto & NFT Mastery: From Basics to Advanced By - CA Raj K Agrawal, Chartered Accountant View Program Office Productivity Microsoft Word Mastery: From Beginner to Expert By - CA Raj K Agrawal, Chartered Accountant View Program Artificial Intelligence(AI) AI for Everyone: Understanding and Applying the Basics on Artificial Intelligence By - Ritesh Vajariya, Generative AI Expert View Program Office Productivity Zero to Hero in Microsoft Excel: Complete Excel guide 2024 By - Metla Sudha Sekhar, IT Specialist and Developer View Program Web Development JavaScript Essentials: Unlock AI-Driven Insights with ChatGPT By - Metla Sudha Sekhar, IT Specialist and Developer View Program Web Development Advanced C++ Mastery: OOPs and Template Techniques By - Metla Sudha Sekhar, IT Specialist and Developer View Program He added that Modi approved 15,000 homes for surrendered Naxals under the Pradhan Mantri Awas Yojana while the National Dairy Development Board would provide at least one cow or buffalo for such families so that they could earn Rs 15,000 to Rs 20,000 every month. "You all should pass on the message to your former colleagues that violence is not the way forward. All Naxals should come forward and surrender. The government will take care of their needs," he said. He also told the surrendered militants to send a simple post card to the Union home secretary and their problems would be taken care of. The home minister said the government was preparing to host the Olympic Games in Ahmedabad in 2036 and, in the run-up to it beginning 2025, about 35,000 youngsters would be trained so that India might win as many medals as possible. "I want someone from Bastar to win at least one medal in the 2036 Olympics," he said. While interacting with Shah, the surrendered Naxals conveyed how they were benefitting from various government schemes, including jobs in the police and the private sector, and bank loans for starting their own ventures. (You can now subscribe to our Economic Times WhatsApp channel )